Incidence of potential drug-drug interactions with antidiabetic drugs.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmazie

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 26189304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploring the potential impact of hospital ward-based pharmacy interns on drug safety.

  2014cited by this paper
• Contribution of cytochrome P450 isoforms to gliquidone metabolism in rats and human

  2014cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2012cited by this paper
• Role of ACE Inhibitors in Patients with Diabetes Mellitus

  2012cited by this paper
• Potential drug interactions associated with treatments for Type 2 diabetes and its comorbidities: a clinical pharmacology review

  2012cited by this paper
• Statins and risk of new-onset diabetes mellitus.

  2012cited by this paper
• Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications.

  2012cited by this paper
• Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

  2011cited by this paper
• National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

  2011cited by this paper
• IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

  2011cited by this paper
• Dipeptidylpeptidase-4 Inhibitors (Gliptins)

  2010cited by this paper
• Effects of β-blockers on glucose and lipid metabolism

  2010cited by this paper
• Polypharmacy and Combination Therapy in the Management of Hypertension in Elderly Patients with Co-Morbid Diabetes Mellitus

  2010cited by this paper
• The incidence of potential drug–drug interactions in elderly patients with arterial hypertension

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.

  2010cited by this paper
• Effect of a multifactorial intervention on mortality in type 2 diabetes.

  2008cited by this paper
• Effects of Gatifloxacin and Levofloxacin on Rates of Hypoglycemia and Hyperglycemia Among Elderly Hospitalized Patients

  2007cited by this paper
• Gatifloxacin acutely stimulates insulin secretion and chronically suppresses insulin biosynthesis.

  2006cited by this paper
• Thiazide diuretics in the treatment of hypertension: an update.

  2006cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

  2005cited by this paper
• Hypoglycemia in Inpatients After Gatifloxacin or Levofloxacin Therapy: Nested Case‐Control Study

  2005cited by this paper
• A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone

  2005cited by this paper
• Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

  2004cited by this paper
• Drug-drug interactions among elderly patients hospitalized for drug toxicity.

  2003cited by this paper
• The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

  2003cited by this paper
• New treatment guidelines for a patient with diabetes and hypertension.

  2003cited by this paper
• [Quality of prescription drug use in patients with type 2 diabetes mellitus in Germany].

  2003cited by this paper
• Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide

  2003cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Beta-Blockers and Diabetes: The Bad Guys Come Good

  2002cited by this paper
• Preventing drug interactions by online prescription screening in community pharmacies and medical practices

  2001cited by this paper

• Epidemiology of potential drug- drug interactions in hospitalized patients with type 2 diabetes mellitus in China: a retrospective study

  2024influential citation
• Prevalence and associated factors of severe proton pump inhibitors drug interactions in community pharmacy: a network analysis approach.

  2023cites this paper
• Rutaecarpine enhances the anti-diabetic activity and hepatic distribution of metformin via up-regulation of Oct1 in diabetic rats

  2021cites this paper
• CLINICAL SIGNIFICANCE OF POTENTIAL DRUG-DRUG INTERACTIONS AND THEIR TARGETS FOR MINIMIZATION AMONG HYPERTENSIVE DIABETIC OUTPATIENTS AT A KENYAN REFERRAL HOSPITAL

  2020cites this paper
• Nuspojave antidijabetika prijavljene Hrvatskoj agenciji za lijekove i medicinske proizvode

  2018cites this paper
• Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter

  2018cites this paper
• Concurrent Use of Sulfonylureas and Antimicrobials of the Elderly in Korea: A Potential Risk of Hypoglycemia

  2018cites this paper
• Drug Utilization Study at Tertiary Care Hospitals in Punjab

  2017cites this paper
• Clinically and pharmacologically relevant interactions of antidiabetic drugs

  2016cites this paper